Showing results (1331-1340 of 1,397) with videos related to

Sort By:
Pageof 140
Blood Advances|February 9, 2021
JMJD6 promotes self-renewal and regenerative capacity of hematopoietic stem cellsHannah Lawson, Catarina Sepulveda, Louie N van de Lagemaat, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 5, 2012
A novel link between Campylobacter jejuni bacteriophage defence, virulence and Guillain-Barré syndromeR Louwen, D Horst-Kreft, A G de Boer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2015
Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105Melinda L Telli, Kristin C Jensen, Shaveta Vinayak, et al.
The Oncologist|March 11, 2022
Homologous Recombination Deficiency: Concepts, Definitions, and AssaysMark D Stewart, Diana Merino Vega, Rebecca C Arend, et al.
Plos One|February 4, 2021
Short-term occupations at high elevation during the Middle Paleolithic at Kalavan 2 (Republic of Armenia)Ariel Malinsky-Buller, Philip Glauberman, Vincent Ollivier, et al.
Plos Pathogens|July 16, 2013
Ethnic variation in inflammatory profile in tuberculosisAnna K Coussens, Robert J Wilkinson, Vladyslav Nikolayevskyy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2017
Long-Term Responders on Olaparib Maintenance in High-Grade Serous Ovarian Cancer: Clinical and Molecular CharacterizationStephanie Lheureux, Zhongwu Lai, Brian A Dougherty, et al.
Bioorganic & Medicinal Chemistry Letters|February 25, 2006
N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptakeJ R Boot, S L Boulet, B P Clark, et al.
The Lancet. Respiratory Medicine|December 6, 2014
Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trialAdrian R Martineau, Wai Yee James, Richard L Hooper, et al.
Pageof 140